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ABSTRACT Upon invasion of Lewis rat macrophages, Toxoplasma rapidly induces
programmed cell death (pyroptosis), which prevents Toxoplasma replication, possibly
explaining the resistance of the Lewis rat to Toxoplasma. Using a chemical mutagen-
esis screen, we identified Toxoplasma mutants that no longer induced pyroptosis.
Whole-genome sequencing led to the identification of three Toxoplasma parasito-
phorous vacuole-localized dense granule proteins, GRA35, GRA42, and GRA43, that
are individually required for induction of Lewis rat macrophage pyroptosis. Macro-
phage infection with Δgra35, Δgra42, and Δgra43 parasites led to greatly reduced
cell death rates and enhanced parasite replication. Lewis rat macrophages infected
with parasites containing a single, double, or triple deletion of these GRAs showed
similar levels of cell viability, suggesting that the three GRAs function in the same
pathway. Deletion of GRA42 or GRA43 resulted in GRA35 (and other GRAs) being re-
tained inside the parasitophorous vacuole instead of being localized to the parasito-
phorous vacuole membrane. Despite having greatly enhanced replication in Lewis
rat macrophages in vitro, Δgra35, Δgra42, and Δgra43 parasites did not establish a
chronic infection in Lewis rats. Toxoplasma did not induce F344 rat macrophage py-
roptosis, but F344 rats infected with Δgra35, Δgra42, and Δgra43 parasites had re-
duced cyst numbers. Thus, these GRAs determined parasite in vivo fitness in F344
rats. Overall, our data suggest that these three Toxoplasma dense granule proteins
play a critical role in establishing a chronic infection in vivo, independently of their
role in mediating macrophage pyroptosis, likely due to their importance in regulat-
ing protein localization to the parasitophorous vacuole membrane.
IMPORTANCE Inflammasomes are major components of the innate immune system
and are responsible for detecting various microbial and environmental danger sig-
nals. Upon invasion of Lewis rat macrophages, the parasite rapidly activates the
NLRP1 inflammasome, resulting in pyroptosis and elimination of the parasite’s repli-
cation niche. The work reported here revealed that Toxoplasma GRA35, GRA42, and
GRA43 are required for induction of Lewis rat macrophage pyroptosis. GRA42 and
GRA43 mediate the correct localization of other GRAs, including GRA35, to the para-
sitophorous vacuole membrane. These three GRAs were also found to be important for
parasite in vivo fitness in a Toxoplasma-susceptible rat strain, independently of their role
in NLRP1 inflammasome activation, suggesting that they perform other important func-
tions. Thus, this study identified three GRAs that mediate the induction of Lewis rat
macrophage pyroptosis and are required for pathogenesis of the parasite.
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Toxoplasma is an obligate intracellular protozoan parasite that infects a wide varietyof warm-blooded animals (1). Among its different hosts, there are natural differ-
ences in susceptibility to the parasite. Most laboratory mouse strains are susceptible to
infection and can succumb after low-dose injection of virulent parasite strains. Rats and
humans are relatively resistant to Toxoplasma. Most rat strains remain asymptomatic
after infection, but the parasite establishes a chronic infection by developing into cysts
in brain and muscle tissues. However, the Lewis rats can clear the parasite, leading
to failure to develop a chronic infection (2). This resistance was shown to be a myeloid
cell-intrinsic dominant trait that mapped to the Toxo1 locus containing Nlrp1
(nucleotide-binding oligomerization domain, leucine-rich repeat protein 1), which en-
codes for the NLRP1 inflammasome sensor (3, 4). In vitro, Lewis rat bone marrow-
derived macrophages (BMDMs) are sensitive to Toxoplasma-induced cell death and
secrete mature interleukin-1 (IL-1) (4, 5). Because Lewis rat macrophages die rapidly
upon Toxoplasma invasion, parasites are released into the extracellular space before
replication can occur (4, 5). We and others previously established, using different inbred
rat strains and recombinant inbred lines derived from crosses between resistant and
susceptible rats, that there is a perfect correlation between sensitivity to Toxoplasma-
induced macrophage cell death and decreased parasite proliferation, IL-1/IL-18 pro-
cessing, rat resistance to Toxoplasma infection, and NLRP1 sequence (4–6). Further-
more, we have shown that macrophage cell death is mediated by Lewis rat NLRP1 as
knockdown of Nlrp1 inhibited cell death whereas expression of the Lewis Nlrp1 allele in
F344 rat macrophages made them susceptible to Toxoplasma-induced cell death (5).
The inflammasomes are a family of cytosolic pattern recognition receptors (PRRs).
Activation of the sensor leads to the formation of a multimeric complex and the
recruitment and proteolytic activation of pro-caspase-1. Caspase-1 cleaves the cyto-
kines pro-IL-1 and pro-IL-18, resulting in their release from cells. Active caspase-1 also
cleaves gasdermin D (GSDMD), which can subsequently form pores in the host cell
membrane and is therefore an essential trigger for a type of host cell death termed
pyroptosis (7, 8). Pyroptosis is a highly inflammatory form of programmed cell death
that occurs most frequently upon infection with intracellular pathogens and has been
established as a host mechanism to promote the rapid clearance of various microbial
infections by removing their intracellular replication niche (9). As macrophages are
among the predominant cell types that are infected upon Toxoplasma infection (10), it
is possible that macrophage pyroptosis is a host mechanism to prevent parasite
proliferation inside the host. Furthermore, the cytokines released from pyroptotic
macrophages might attract other immune cells to fight the infection. Infected macro-
phages and dendritic cells are also involved in promoting Toxoplasma dissemination by
migrating to distant sites (11–13), and therefore Toxoplasma-induced pyroptosis of
these cells could also inhibit Toxoplasma dissemination.
The specific stimuli that can activate the NLRP1 inflammasome resulting in pyrop-
tosis and their mechanisms of activation differ. Anthrax lethal toxin (LT) is a protease
and a direct activator of rat NLRP1 (14). LT cleaves the N terminus of NLRP1 in
LT-susceptible mouse and rat macrophages. This cleavage is sufficient to activate the
NLRP1 inflammasome and induce pyroptosis (15, 16). Val-boroPro (VbP), a nonselective
inhibitor of post-proline cleaving serine proteases, activates the NLRP1 inflammasome
and triggers pyroptosis of monocytes and macrophages via inhibition of the cytosolic
serine dipeptidases Dpp8 and Dpp9 (17, 18). However, unlike what was shown for LT,
VbP activation of the NLRP1 inflammasome does not involve direct proteolysis (18).
NLRP1 inflammasome activation by Toxoplasma in mice was also recently evaluated (6,
19). No cleavage of the mouse NLRP1 was observed in parasite-infected cells, suggest-
ing that the NLRP1 response to Toxoplasma in mice might be independent of cleavage
(6). However, the parasite protein(s) involved in activation of the NLRP1 inflammasome
is unknown.
To further explore the mechanism of activation of the Lewis rat NLRP1 inflam-
masome by Toxoplasma, we chose to take an unbiased approach to identify the
Toxoplasma gene product(s) required for induction of Lewis rat BMDM pyroptosis.
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Using a chemical mutagenesis screen followed by whole-genome sequencing, we
identified three Toxoplasma dense granule proteins (GRA35, GRA42, and GRA43) that
are required for induction of Lewis rat macrophage pyroptosis. Parasite strains deficient
in GRA35, GRA42, or GRA43 induce significantly less pyroptosis and IL-1 processing
and secretion but have enhanced replication. These results indicate that Toxoplasma
dense granule proteins are involved in NLRP1 inflammasome activation.
RESULTS
The NLRP3 inflammasome is not involved in Toxoplasma-induced Lewis rat
macrophage pyroptosis. We previously showed that Toxoplasma activates the NLRP1
inflammasome in Lewis rat macrophages, resulting in pyroptosis (5). Toxoplasma
activates both the NLRP1 and NLRP3 inflammasomes in mice (19), but it is not known
whether Toxoplasma also activates the NLRP3 inflammasome in Lewis rat macrophages.
To investigate this, Lewis rat macrophages were treated with the NLRP3 inflammasome
inhibitor MCC950 (20) or with the caspase-1 inhibitor VX765 (which should inhibit all
inflammasomes) (21) followed by Toxoplasma type I (RH) parasite infection. Infected
macrophages treated with VX765 showed significantly higher cell viability than non-
treated macrophages, whereas treatment with MCC950 did not prevent parasite-
induced cell death (Fig. 1). VX765 and MCC950 did not inhibit parasite invasion in Lewis
rat macrophages (Fig. S1A) or parasite growth in human foreskin fibroblasts (HFFs)
(Fig. S1B). As a positive control, MCC950 inhibited cell death and IL-1 release in
response to nigericin, a known NLRP3 agonist, in lipopolysaccharide (LPS)-primed Lewis
rat macrophages (Fig. S1C and D). Therefore, Lewis rat macrophage cell death upon
Toxoplasma infection is likely entirely dependent on NLRP1.
Pyroptosis of Lewis rat macrophages is dependent on Toxoplasma Golgi-
protease ASP5 but not on the MYR1 translocon. To better understand the mecha-
nism of NLRP1 inflammasome activation, we aimed to discover the Toxoplasma pro-
tein(s) that induces Lewis rat macrophage pyroptosis. We focused on parasite secretory
proteins that can potentially interact with host cytosolic NLRP1 or with other host
cytosolic proteins that modulate the activity of the inflammasome. Upon invasion,
Toxoplasma secretes rhoptry proteins (ROPs) into the host cell cytosol (22). We previ-
ously showed that parasites treated with mycalolide B, a compound that blocks
Toxoplasma invasion but allows secretion of microneme and rhoptry contents, were
unable to induce Lewis rat macrophage IL-1 secretion and cell death (5), suggesting
that ROPs are not the parasite effectors that activate the NLRP1 inflammasome. Once
FIG 1 The NLRP3 inflammasome is dispensable for Toxoplasma-induced Lewis rat macrophage cell
death and IL-1 secretion. Lewis rat BMDMs with or without pretreatment with either 50 M VX765 or
10 M MCC950 for 2 h were subjected to infection with Toxoplasma type I (RH) parasites (MOI  0.5) for
24 h. Macrophage viability was measured via 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay. Data are displayed as paired scatterplots (left; n  3; *,
P 0.05; ns, not significant [Student’s t test]). The right scatterplots show the cell viability difference
between infected BMDMs with and without treatment in each paired experiment. Horizontal bars
represent the median cell viability difference.
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the parasite resides inside a host cell in a nonfusogenic parasitophorous vacuole (PV),
dense granules discharge GRAs into the PV lumen, where some stay while others
eventually become associated with the PV membrane (PVM) or are exported into the
host cytosol (23). Toxoplasma aspartyl protease 5 (ASP5), a Golgi-resident protease
related to Plasmodium plasmepsin V, mediates the export of GRAs to the host cytosol
and can influence the localization of several GRAs to the PVM (24–26). To investigate
whether GRAs that localize at the PVM or GRAs that are exported to the host cytosol
induce Lewis macrophage cell death, the viability of Lewis rat macrophages infected
with Δasp5 parasites was measured (Fig. 2A). Infection by Δasp5 parasites induced less
macrophage cell death than wild-type (WT) parasite infection, and Δasp5 parasites
complemented with a Ty-tagged copy of ASP5 regained the ability to induce cell death
(Fig. 2A, right panel). MYR1, a putative Toxoplasma PVM translocon, mediates the
export of GRAs, including GRA16 and GRA24, into the host cytosol (27). Δmyr1 parasites
(Fig. S2A and C) induced levels of Lewis rat macrophage cell death similar to those seen
with WT parasites (Fig. 2B). Taking the data together, Toxoplasma-induced Lewis rat
macrophage cell death is ASP5 but not MYR1 dependent, suggesting that GRAs that
localize to the PVM, but not GRAs exported to the host cytosol, are likely mediators of
Lewis macrophage pyroptosis.
Isolation of Toxoplasma mutants that do not induce Lewis macrophage pyrop-
tosis. Although GRAs that localize to the PVM are likely involved in Lewis macrophage
pyroptosis, the exact protein(s) involved is still unknown. To identify the Toxoplasma
FIG 2 Toxoplasma-induced Lewis rat macrophage cell death is ASP5 dependent but not MYR1 depen-
dent. (A) Lewis rat BMDMs were infected with WT parasites, ASP5 knockout parasites (Δasp5), or ASP5
knockout parasites complemented with a Ty-tagged copy of ASP5 (ASP5-Ty) (MOI  1) for 24 h.
Macrophage viability was measured via MTS assay. Data are displayed as paired scatterplots (left; n  4;
*, P 0.05 [Student’s t test]). The right scatterplots show the cell viability difference between the
indicated strains and WT parasites in each paired experiment. Horizontal bars represent the median cell
viability difference. (B) Lewis rat BMDMs were infected with WT parasites or two independent clones of
MYR1 knockout parasites (Δmyr1 #1 and Δmyr1 #2) (MOI  1) for 24 h. Macrophage viability was
measured via MTS assay. Data are displayed as paired scatterplots (left; n  4 for WT and Δmyr1 #1 and
n  3 for Δmyr1 #2; ns, not significant [Student’s t test]). The right scatterplots show the cell viability
difference between Δmyr1 parasites and WT parasites in each paired experiment. Horizontal bars
represent the median cell viability difference.
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gene product(s) required for activation of Lewis macrophage pyroptosis, we designed
a chemical mutagenesis screen to isolate mutants that fail to induce cell death (Fig. 3A).
Type I (RH) parasites were mutagenized by the use of N-ethyl-N-nitrosourea (ENU) or
ethyl methanesulfonate (EMS). The populations of chemically mutagenized parasites
were used to infect Lewis rat macrophages at a multiplicity of infection (MOI) of 0.2 to
0.3. Toxoplasma-induced pyroptosis is a dominant trait (5); reinvasion of parasites into
the rare cells containing Toxoplasma mutants that do not activate pyroptosis would
therefore still lead to macrophage cell death. Therefore, to inhibit reinvasion, extracel-
lular parasites were washed from cells after 2 h of infection and the medium was
replaced with fresh medium that contained the glycosaminoglycan dextran sulfate
(DS), a glycan competitor that prevents host cell invasion by extracellular parasites (28).
Parasites that retained the ability to induce cell death were released from the lysed cell
into the supernatant, where the parasite was coated with DS, blocking reinvasion into
a new host cell. Mutated parasites unable to induce cell death were able to replicate
within the surviving macrophage. After 24 h of infection, the surviving cells were
washed, thereby removing the extracellular parasites capable of inducing cell death
from the population. The surviving macrophages were then added to a monolayer of
human foreskin fibroblasts (HFFs) so the parasites within the macrophages could
continue to replicate until their natural egress from the macrophages.
After seven rounds of selection, a distinct phenotype (the level of viability of Lewis
rat macrophages upon Toxoplasma infection is more than 50%) began to emerge in
two independent populations of mutagenized parasites compared to WT and dimethyl
FIG 3 Isolation of Toxoplasma mutants that do not induce Lewis rat macrophage cell death. (A) Schematic of mutagenesis screen. DS, dextran sulfate; BMDMs,
bone marrow-derived macrophages. (B) Lewis rat BMDMs were infected with indicated mutagenized parasites (MOI  1) for 24 h. Macrophage viability was
measured via MTS assay. Data are displayed in columns (n  1). (C) Lewis rat BMDMs were infected with WT parasites or independent mutant strains isolated
from the pool of mutagenized parasites (Mutant #1, Mutant #2, and Mutant #3) (MOI  1) for 24 h. Macrophage viability was measured via MTS assay. Data
are displayed as paired scatterplots (left; n 8 for WT, n  11 for mutant 1, n  17 for mutant 2, n  8 for mutant 3; ***, P 0.001; ****, P 0.0001 [Student’s
t test]). The right scatterplots show the cell viability difference between the indicated mutant strains and WT parasites in each paired experiment. Horizontal
bars represent the median cell viability difference. (D) Lewis rat BMDMs were infected with the strains used as described for panel C (MOI  0.5) for 24 h. The
number of parasites per vacuole was quantified by microscopy. A total of 100 to 120 vacuoles were counted per experiment. Data are displayed as average
values (n  4; error bars,  standard deviations [SD]; ****, P 0.0001 [two-way analysis of variance {ANOVA} comparing mutants to WT]). (E) Western blot
probing for IL-1 on concentrated (20) supernatants of LPS-primed (100 ng/ml, 2 h) Lewis rat BMDMs infected with the strains used as described for panel
C (MOI  1) for 24 h. The image is representative of results from two experiments; pro-IL-1 is 37 kDa; active IL-1 is 17 kDa; the aspecific band is represented
by an asterisk and indicates similar levels of loading of samples.
Three Toxoplasma GRAs Mediate Macrophage Pyroptosis ®
January/February 2019 Volume 10 Issue 1 e02388-18 mbio.asm.org 5
 o
n
 January 8, 2019 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
sulfoxide (DMSO)-treated parasites (Fig. 3B). After a further two rounds of selection,
single parasites were cloned from the populations and individual clones were tested for
their inability to induce pyroptosis. Three independent mutant clones induced signif-
icantly less Lewis rat macrophage cell death (Fig. 3C). Macrophage survival was linked
to the ability of the parasite to replicate within the macrophage. As expected, 75% of
the surviving macrophages infected with WT parasites contained only single parasites
whereas only 25% of cells infected with the mutants contained single parasites
(Fig. 3D). Cell death mediated by inflammasome activation (pyroptosis) is characterized
by active IL-1 secretion. We found a strong decrease in the amount of cleaved active
IL-1 (17 kDa) secreted from macrophages infected with each of the mutant strains
compared to WT results (Fig. 3E). Thus, the forward genetic selection strategy was
successful in yielding Toxoplasma mutants deficient in the induction of Lewis rat
macrophage pyroptosis.
Identification of single nucleotide variations in the mutants. To identify the
genes mutated in each clone, we performed whole-genome sequencing of each
mutant. Sequence comparisons relative to the parental strain revealed 16, 11, and 12
nonsynonymous mutations in mutant 1, mutant 2, and mutant 3, respectively (Table 1).
The three mutants did not have any mutated genes in common. To identify the
causative mutations in these mutants, we established a set of criteria to shorten the list
TABLE 1 List of all identified nonsynonymous mutationsa
Chromosome Position Ref Sub Codon change AA change Gene Mut no.
TGGT1_chrXII 3698939 C T Cgt/Tgt R/C TGGT1_248260 1
TGGT1_chrXI 4323464 A G cTc/cCc L/P TGGT1_314875 1
TGGT1_chrX 5454719 A T Tga/Aga */R TGGT1_236870 1
TGGT1_chrVIII 3546892 A G Aca/Gca T/A TGGT1_273510 1
TGGT1_chrVIIb 258249 C G Ccg/Gcg P/A TGGT1_263360 1
TGGT1_chrVIIb 1300287 A G tTc/tCc F/S TGGT1_262825 1
TGGT1_chrVIIb 4053654 G C Ccg/Gcg P/A TGGT1_257500 1
TGGT1_chrVIIa 683027 A G Ttc/Ctc F/L TGGT1_206550 1
TGGT1_chrVIIa 1666878 A G tTg/tCg L/S TGGT1_204310 1
TGGT1_chrV 2683109 A C Ttg/Gtg L/V TGGT1_284040 1
TGGT1_chrIX 1745808 G A cCc/cTc P/L TGGT1_264890 1
TGGT1_chrIX 3803976 T C Tct/Cct S/P TGGT1_290960 1
TGGT1_chrIII 527809 A T aaA/aaT K/N TGGT1_252395 1
TGGT1_chrIII 1241431 C T Gac/Aac D/N TGGT1_253870 1
TGGT1_chrIb 814454 A T cTg/cAg L/Q TGGT1_208580 1
TGGT1_chrVIIa 2153702 GA A GAg/Aga E/R TGGT1_204050 1
TGGT1_chrIV 2235861 G A cGa/cAa R/Q TGGT1_301250 2
TGGT1_chrVIIa 2964132 C G ttG/ttC L/F TGGT1_203040 2
TGGT1_chrVI 290424 T C Aaa/Gaa K/E TGGT1_239130 2
TGGT1_chrVI 3356628 G C Gga/Cga G/R TGGT1_243635 2
TGGT1_chrV 121175 A G aTc/aCc I/T TGGT1_220175 2
TGGT1_chrXII 5959927 A C cAt/cCt H/P TGGT1_278518 2
TGGT1_chrVIII 2061823 T C Agt/Ggt S/G TGGT1_231410 2
TGGT1_chrVIIb 730342 C T Cgt/Tgt R/C TGGT1_264140 2
TGGT1_chrVIIb 2573674 G A cCa/cTa P/L TGGT1_260450 2
TGGT1_chrVIIb 3451345 A G gAt/gGt D/G TGGT1_258580 2
TGGT1_chrX 5567109 C T tGg/tAg W/* TGGT1_237015 2
TGGT1_chrIX 2023395 T C gAa/gGa E/G TGGT1_264472 3
TGGT1_chrV 1043175 T C Acg/Gcg T/A TGGT1_213610 3
TGGT1_chrVI 1514625 A T gAt/gTt D/V TGGT1_240960 3
TGGT1_chrVI 674303 C T aGa/aAa R/K TGGT1_239700 3
TGGT1_chrVIIa 1197377 C G Gcc/Ccc A/P TGGT1_205160 3
TGGT1_chrVIII 2566377 G T gaG/gaT E/D TGGT1_233120 3
TGGT1_chrX 1583637 A T Aaa/Taa K/* TGGT1_226380 3
TGGT1_chrX 3027043 T A Agc/Tgc S/C TGGT1_224280 3
TGGT1_chrX 401396 T C Agt/Ggt S/G TGGT1_228210 3
TGGT1_chrXI 2517037 A G cAc/cGc H/R TGGT1_312140 3
TGGT1_chrXII 1102624 T C Aag/Gag K/E TGGT1_219070 3
TGGT1_chrXII 6691803 T C aAg/aGg K/R TGGT1_277030 3
aAA, amino acid; Ref, reference nucleotide(s) in WT strain (GT1 v9.0); Sub, nucleotide variant(s); Mut, mutant
clone number; *, stop codon.
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of possible genes. The inflammasomes are expressed and assembled within the cyto-
plasm of host cells. We therefore chose to focus on those Toxoplasma genes whose
protein products contained predicted signal peptides. Additionally, we had previously
tested a large number of different Toxoplasma strains for their ability to activate cell
death (5); all strains tested were able to induce cell death. We therefore focused on the
genes that were expressed (fragments per kilobase per million [FPKM] of10) across all
strains based on our published transcriptome sequencing (RNA-seq) data set for these
strains (29). Using these criteria, we shortened the list of candidate genes in these
mutants to seven (Fig. 4A).
To determine which of these genes are involved in activation of Lewis rat macro-
phage cell death, we individually disrupted each candidate gene in the RH background
FIG 4 Three genes are individually required to induce cell death in Lewis rat BMDMs. (A) List of genes containing nonsynonymous polymorphisms that fulfill
candidate gene criteria in isolated mutants. (B) Lewis rat BMDMs were infected with WT parasites or with parasites in which TGGT1_248260, SUB1, TGGT1_203040,
or ROP17 was knocked out (ΔTGGT1_248260, Δsub1, ΔTGGT1_203040, or Δrop17) (MOI  1) for 24 h. Macrophage viability was measured via MTS assay. Data
are displayed on the left as paired scatterplots (n  2; ns, not significant [Student’s t test]). The right scatterplots show the cell viability difference between the
indicated knockout strains and WT parasites in each paired experiment. Horizontal bars represent the median cell viability difference. (C) Cell viability as assessed
by MTS assay of Lewis rat BMDMs infected with WT parasites or with parasites in which GRA35, TGGT1_237015, or TGGT1_236870 was knocked out (Δgra35,
ΔTGGT1_237015, or ΔTGGT1_236870) or with knockout parasites complemented with WT alleles of GRA35, TGGT1_237015, or TGGT1_236870 (Δgra35 GRA35,
ΔTGGT1_237015 TGGT1_237015, or ΔTGGT1_236870 TGGT1_236870) (MOI  1) for 24 h. Data are displayed on the left as paired scatterplots (n 16 for WT,
n  28 for Δgra35, n  7 for Δgra35 GRA35, n  19 for ΔTGGT1_237015, n  4 for ΔTGGT1_237015 TGGT1_237015, n  16 for ΔTGGT1_236870, n  4 for
ΔTGGT1_236870 TGGT1_236870; *, P 0.05; **, P 0.01; ****, P 0.0001; ns, not significant [Student’s t test]). The right scatterplots show the cell viability
difference between the indicated strains and WT parasites in each paired experiment. Horizontal bars represent the median cell viability difference. (D) Number
of parasites per vacuole were measured in Lewis rat BMDMs infected with the strains used as described for panel C (MOI  0.5) at 24 h postinfection. A total
of 100 to 120 vacuoles were counted per experiment. Data are displayed as average values (n  5 for WT and ΔTGGT1_237015, n  4 for Δgra35, n  3 for
ΔTGGT1_236870, n  2 for all the complementation strains; error bars,  SD; **, P 0.01; ***, P 0.001; ****, P 0.0001 [two-way ANOVA multiple
comparisons]). (E) Lewis rat BMDMs were infected with type II WT parasites or type II parasites in which GRA35, TGME49_237015, or TGME49_236870 was knocked
out (Δgra35II, ΔTGME49_237015, or ΔTGME49_236870) (MOI  1) for 24 h. Macrophage viability was measured via MTS assay. Data are displayed as paired
scatterplots (left; n 4 for WT; n  5 for Δgra35II and ΔTGME49_237015; n  4 for ΔTGME49_236870; **, P 0.01; ***, P 0.001; ****, P 0.0001 [Student’s t
test]). The right scatterplots show the cell viability difference between the indicated knockout strains and WT parasites in each paired experiment. Horizontal
bars represent the median cell viability difference.
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(Fig. S2A and C) and tested the resulting strains for their inability to induce cell death.
Parasites in which we knocked out TGGT1_248260, SUB1, TGGT1_203040, or ROP17
induced levels of cell death similar to those induced by WT parasites (Fig. 4B). Mutant
3 has only one candidate gene, TGGT1_226380, encoding GRA35 (30). A mutation in this
gene resulted in an early stop codon (Fig. 4A; see also Fig. S3A). In mutant 2, a mutation
in TGGT1_237015 also resulted in an early stop codon (Fig. 4A; see also Fig. S3A). In
mutant 1, a mutation in the stop codon of TGGT1_236870 converted this stop codon
into an arginine (R), which resulted in an extended gene product (Fig. 4A; see also
Fig. S3A). Lewis rat macrophages infected with parasites that contained individual
disruptions in GRA35, TGGT1_237015, or TGGT1_236870 showed significantly less cell
death than macrophages infected with WT parasites (Fig. 4C). Complementation of
knockout strains with WT alleles of GRA35, TGGT1_237015, and TGGT1_236870 restored
their ability to induce cell death (Fig. 4C). The replication of Δgra35, ΔTGGT1_237015,
and ΔTGGT1_236870 parasites in infected Lewis rat macrophages was significantly
enhanced compared to the levels seen with WT parasites and complemented parasites
24 h after infection (Fig. 4D). Similarly, type II (ME49) parasites in which GRA35,
TGME49_237015, or TGME49_236870 was disrupted (Fig. S2C) induced lower levels of
Lewis macrophage cell death than were seen with macrophages infected with WT
parasites (Fig. 4E). We also sequenced these 3 genes in other independent mutants.
Another mutation (Y121 mutant to stop codon) in GRA35 was also found in one of these
mutant clones (named mutant 4), which failed to induce pyroptosis (Fig. S3A and S4).
These results indicated that the gene products of GRA35, TGGT1_237015, and
TGGT1_236870 mediated Toxoplasma-induced Lewis rat macrophage cell death.
TGGT1_236870 and TGGT1_237015 Code for novel PV-localized dense granule
proteins. GRA35 was identified as a novel PV-localized dense granule protein by Bio-ID
using other GRAs as baits (30), but there are no reports on the gene products encoded
by TGGT1_237015 and TGGT1_236870. GRA35, TGGT1_237015, and TGGT1_236870 are
small one-exon genes that are expressed in all Toxoplasma life stages except in the
sexual stages inside the cat (www.toxodb.org). The predicted protein products of these
genes lack predicted functional domains except for the C-terminal coiled-coil domain
of GRA35 (Fig. S3A). Each of the resulting proteins has a signal peptide and one
predicted transmembrane (TM) domain and is generally predicted to be very alpha
helical except the gene product of TGGT1_236870 (Fig. S3A). No Toxoplasma export
element (TEXEL [RRLxx]) motif (24) is present in the amino acid sequence of GRA35,
TGGT1_237015, and TGGT1_236870. Although the corresponding three genes are quite
highly conserved among different Toxoplasma strains, the rates of nonsynonymous/
synonymous (NS/S) polymorphisms among 64 different strains are higher at the C
terminus (starting after the TM domain) of each gene product (Fig. S3B to D). BLAST
analysis of the entire protein sequence revealed no predicted function of these three
genes. Orthologs of GRA35, TGGT1_237015, and TGGT1_236870 were identified in other
tissue cyst-forming coccidia, namely, Hammondia hammondi, Neospora caninum,
and Besnoitia besnoiti (Fig. S5). We also found that three Toxoplasma proteins,
TGGT1_225160, GRA36 (TGGT1_213067), and TGGT1_257970, shared high (40%)
amino acid similarity with GRA35 (Fig. S5A). Parasites deficient in TGGT1_225160, GRA36,
or TGGT1_257970 induced levels of Lewis rat macrophage cell death similar to those
seen with infection with WT parasites, suggesting that these proteins do not share the
GRA35 function that mediates Lewis rat macrophage cell death (Fig. S6).
To characterize GRA35, TGGT1_237015, and TGGT1_236870, we generated comple-
mented strains in which a C-terminally hemagglutinin (HA)-tagged version of each
gene product is expressed from its endogenous promoter in the respective knockout
strains. The expression of each protein was confirmed by Western blotting (Fig. 5A). The
extracellular and intracellular parasites yielded bands migrating at the same size,
suggesting that GRA35, TGGT1_237015, and TGGT1_236870 did not undergo proteo-
lytic modification in the process of secretion. The subcellular localization of each
protein was observed in extracellular parasites. As previously reported, GRA35 is a
dense granule protein that localized at punctuate structures which overlapped GRA7
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while being excluded from rhoptries (Fig. 5B). The gene products of TGGT1_237015 and
TGGT1_236870 also showed colocalization with GRA7 but not with ROP1 (Fig. 5B). The
three proteins were localized at the PVM and PV lumen in intracellular parasites (see
Fig. 7B, upper row), suggesting that they are indeed secreted via dense granules. We
concluded from these data that TGGT1_236870 and TGGT1_237015 are novel dense
granule proteins; therefore, we named them GRA42 and GRA43, respectively.
Complementation of mutants with GRA35, GRA42, and GRA43 restores their
ability to induce Lewis rat macrophage pyroptosis. To confirm that the mutation in
GRA35, GRA42, and GRA43 was indeed responsible for the failure of our chemically
mutagenized parasites to induce cell death, we expressed the WT allele of the gene in
each mutant. Addition of the WT version of GRA35, GRA42, and GRA43 to the respective
mutants was sufficient to restore induction of cell death (Fig. 6A). Similarly, macro-
phages infected with mutant strains expressing the WT version of GRA35, GRA42, or
GRA43 contained fewer replicating parasites than the mutant-infected BMDMs (Fig. 6B).
We also observed an increase in the level of active IL-1 secreted from macrophages
infected with the complemented strains compared to their mutant counterparts
(Fig. 6C). Overall, these data indicate that GRA35, GRA42, and GRA43 are required for
induction of Lewis rat macrophage pyroptosis by Toxoplasma.
GRA42 and GRA43 influence the correct localization of GRA35, and of other
GRAs, to the PVM. Lewis rat macrophages infected with individual knockouts of
GRA35, GRA42, or GRA43 showed a level of reduced cell death similar to that shown by
macrophages infected with WT parasites (Fig. 4C, right panel). It is therefore likely that
these three GRAs function in the same pathway that induces cell death. To confirm this,
we generated double and triple GRA35, GRA42, and GRA43 knockout parasites (Fig. S2B
and C). Single, double, and triple GRA35, GRA42, and GRA43 knockout parasites induced
similar levels of macrophage cell death (Fig. 7A), indicating that these GRAs function in
the same pathway. Possibly, they form a protein complex that activates the inflam-
masome or one of the GRAs activates the inflammasome and the other two are
upstream in the pathway. To investigate this possibility, we first determined the
localization of GRA35, GRA42, and GRA43 in intracellular parasites expressing a
C-terminally hemagglutinin (HA)-tagged version of each gene product driven by its
endogenous promoter. GRA35 localized at the PVM, while GRA42 and GRA43 were
predominantly localized in the PV lumen (Fig. 7B, upper row). We then determined the
localization of GRA35, GRA42, and GRA43 in the different knockout parasites. In Δgra42
and Δgra43 parasites, GRA35 was mostly retained in the PV lumen and less of it was
localized to the PVM, whereas the localization of GRA42 and GRA43 was unchanged
FIG 5 TGGT1_236870 and TGGT1_237015 code for novel dense granule proteins GRA42 and GRA43. (A) Strains individually knocked
out in each gene were generated using CRISPR/Cas9 and complemented with an HA-tagged WT version of the gene. HFFs were
infected with HA-expressing parasites for 24 h. Extracellular parasites were removed and washed with PBS prior to lysing (“Extra”). The
remaining infected cells were lysed (“Intra”). SAG-1 was used as the parasite loading control. Predicted sizes: GRA35, 40.3 kDa; GRA42,
29.3 kDa; GRA43, 23.8 kDa. The image is representative of results from two independent experiments. (B) Extracellular parasites
expressing HA-tagged GRA35, GRA42, or GRA43 were fixed, permeabilized, and subjected to immunofluorescent assay with the
indicated antibodies. The images were taken at identical exposure times for each channel (scale bar  2 m). The image is
representative of results from two independent experiments.
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regardless of the presence of GRA35, GRA42, or GRA43 (Fig. 7B, middle two rows).
Previously, we had found that parasites deficient in ASP5 induced lower levels of Lewis
rat macrophage cell death (Fig. 2A). ASP5 deletion also resulted in mislocalization of
certain PVM-localized GRAs (24, 25). To determine whether ASP5 might influence Lewis
rat macrophage cell death through these GRAs, the localization of GRA35, GRA42, and
GRA43 was also observed in parasites lacking ASP5. In Δasp5 parasites, GRA35 no
longer localized to the PVM and was mostly present in the PV space (Fig. 7B, left
bottom). In contrast, ASP5 did not influence the localization of GRA42 and GRA43
(Fig. 7B, middle and right bottom). Therefore, these results revealed that GRA42, GRA43,
and ASP5 influenced the PVM localization of GRA35. To determine whether GRA35 is
the only GRA whose localization is influenced by GRA42 and GRA43, we determined the
localization of GRA17 and GRA23, which are also PVM-localized GRAs, in Δgra42 or
Δgra43 parasites (Fig. 7C). In the WT parasites, these two GRAs were entirely localized
at the PVM (Fig. 7C, top row). In the Δgra42 parasites, GRA17 and GRA23 were
mislocalized to the PV space, although a small fraction localized to the PVM (Fig. 7C,
FIG 6 GRA35, GRA42, and GRA43 restore the mutant phenotype, and are required for inflammasome activation.
(A) Lewis rat BMDMs were infected with WT parasites, with independent mutant strains isolated from the pool of
mutagenized parasites (Mutant #1, Mutant #2 and Mutant #3), or with the mutant strains complemented with WT
alleles of GRA42, GRA43, or GRA35 (Mutant #1 GRA42, Mutant #2 GRA43, Mutant #3 GRA35) (MOI  1) for 24
h. Macrophage viability was measured via MTS assay. Data are displayed on the left as paired scatterplots (n 8
for WT, n  11 for mutant 1, n  17 for mutant 2, n  8 for mutant 3, n  2 for mutant 1 GRA42 and mutant
3 GRA35, n  4 for mutant 2 GRA43; *, P 0.05; **, P 0.01; ***, P 0.001; ****, P 0.0001 [Student’s t test]).
The right scatterplots show the cell viability difference between the indicated strains and WT parasites in each
paired experiment. Horizontal bars represent the median cell viability difference. (B) The number of parasites per
vacuole was measured in Lewis rat BMDMs infected with the strains used as described for panel A (MOI  0.5) at
24 h postinfection. A total of 100 to 120 vacuoles were counted per experiment. Data are displayed as average
values (n  4 for the WT strain and mutants 1, 2, and 3; n  2 for mutant 1 GRA42, mutant 2 GRA43, and
mutant 3 GRA35; error bars,  SD; ****, P 0.0001 [two-way ANOVA multiple comparisons]). (C) Western blot of
IL-1 on concentrated supernatants (20) BMDMs primed with LPS (100 ng/ml, 2 h) infected with the strains used
as described for panel A (MOI 1, 24 h). The image is representative of results from two independent experiments.
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middle row). In the Δgra43 parasites, these two GRAs were mostly absent at the PVM
instead being retained in the PV lumen (Fig. 7C, bottom row). In contrast to GRA42 and
GRA43, deficiency in GRA35 did not result in mislocalization of these two PVM GRAs.
Note that only a small amount of GRA17 is required to mediate normal small-molecule
permeability and to prevent enlarged vacuoles (31), possibly explaining why we had
failed to see the established Δgra17 “bubble vacuole” phenotype in these vacuoles.
Partial or no GRA17/GRA23 PVM staining was observed in more than 80% of the
vacuoles of Δgra42 and Δgra43 parasites (Fig. 7D). Therefore, GRA42 and GRA43 not
only influence GRA35 localization at the PVM but also affect the localization of other
PVM-associated GRAs.
No interaction between Toxoplasma GRA35 and Lewis rat NLRP1 in cotrans-
fected HEK293T cells. GRA35 localized on the PVM, where it might directly interact
with host cytosolic NLRP1. Because cell death occurs rapidly after parasite invasion (5),
it is difficult to detect a putative interaction between GRA35 and NLRP1 in parasite-
FIG 7 GRA42 and GRA43 influence the localization of GRA35, as well as GRA17, to the PVM. (A) Lewis rat BMDMs were infected with WT parasites or with
parasites in which GRA35, GRA42, or GRA43 was knocked out (Δgra35, Δgra42, or Δgra43) or with parasites containing a double knockout of GRA35, GRA42, or
GRA43 (Δgra35 Δgra42, Δgra35 Δgra43, or Δgra42 Δgra43) or with triple knockout parasites (Δgra35 Δgra42 Δgra43) (MOI  1) for 24 h. Macrophage viability
was measured via MTS assay. Data are displayed as paired scatterplots (left; n  4; all knockout strains versus WT; **, P 0.01; ***, P 0.001; ****, P 0.0001
[Student’s t test]). The right scatterplots show the cell viability difference between the indicated strains and WT parasites in each paired experiment. Horizontal
bars represent the median cell viability difference (ns, not significant [one-way ANOVA with Kruskal-Wallis test]). (B) HFFs were infected with WT parasites or
with parasites in which GRA35, GRA42, GRA43, or ASP5 was knocked out (Δgra35, Δgra42, Δgra43, or Δasp5) and that transiently expressed GRA35-HA (left),
GRA42-HA (middle), or GRA43-HA (right). The parasites were fixed and stained with antibodies against the HA epitope (red) and SAG1 (green). Transfected
parasites were GFP positive. Images were taken at identical exposure times for each channel (scale bar  5 m). The image is representative of results from
two independent experiments. (C) HFFs were infected with WT parasites or with parasites in which GRA42 or GRA43 was knocked out (Δgra42 or Δgra43) and
that transiently expressed GRA17-HA (left) or GRA23-HA (right), fixed, and stained with antibodies against SAG1 (green) and the HA epitope (red). Transfected
parasites were GFP positive. The images were taken at identical exposure times for each channel (scale bar 5 m). The image is representative of results from
two independent experiments. (D) Localization of GRA17 or GRA23 (see panel C) in at least 60 vacuoles containing 4 or more parasites were observed and scored
as PVM localization, partial PVM localization, or PV lumen localization. Data are displayed as average values (n  2; error bars,  SD; ***, P 0.001; ****,
P 0.0001 [two-way ANOVA comparing mutants to WT]).
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infected macrophages. To investigate a direct interaction between Lewis rat NLRP1 and
Toxoplasma GRA35, coimmunoprecipitation (co-IP) was performed in HEK293T cells
transiently expressing FLAG-NLRP1 and GRA35-HA. The lysis of cotransfected cells was
subjected to immunoprecipitation by using HA antibody and FLAG antibody. However,
GRA35-HA was not detected in the FLAG-immunoprecipitated fraction, and FLAG-
NLRP1 was not detected in the HA-immunoprecipitated fraction (Fig. 8). Thus, Lewis rat
NLRP1 does not directly interact with Toxoplasma GRA35 in cotransfected HEK293T
cells.
Toxoplasma parasites deficient in GRA35, GRA42, or GRA43 do not establish a
chronic infection in Lewis rats but have reduced fitness in F344 rats in which
Toxoplasma does not activate the NLRP1 inflammasome. Since GRA35, GRA42, and
GRA43 are required for parasite-induced macrophage pyroptosis in vitro, we hypoth-
esized that Toxoplasma strains deficient in these genes would fail to induce macro-
phage cell death in vivo, allowing the parasite to replicate and eventually disseminate
to the brain, leading to chronic infection. Removal of these genes does not lead to a
general defect in parasite fitness in HFFs (32). We also found no significant difference
in the levels of in vitro growth between WT parasites and Δgra35, Δgra42, or Δgra43
parasites in rat fibroblasts (Fig. S7A). Lewis rats were intraperitoneally (i.p.) infected with
the type II ME49 strain expressing red fluorescent protein (RFP) or with the GRA35,
GRA42, or GRA43 knockout strains generated in this background. In addition, suscep-
tible F344 rats, which encode an NLRP1 protein resistant to Toxoplasma-mediated
inflammasome activation (2, 4), were used as a control. Compared to Lewis rat mac-
rophages, F344 rat macrophages did not undergo rapid cell death after infection with
WT, Δgra35, Δgra42, or Δgra43 parasites (Fig. S7B). During the course of infection, none
of the rats lost weight or showed obvious clinical symptoms of toxoplasmosis (data not
shown). After 2 months, the rats were sacrificed and the presence of cysts in the brains
was determined. The brains of F344 rats infected with ME49-RFP parasites contained an
FIG 8 Lewis rat NLRP1 does not interact with Toxoplasma GRA35 in cotransfected HEK293T cells.
HEK293T cells were cotransfected with pcDNA3.1-GRA35-HA and pCMV-FLAG-NLRP1 (expressing Lewis
rat variant of Nlrp1) at a ratio of 1:1. At 30 h after transfection, cells were lysed in IP-lysis buffer (50 mM
Tris [pH 7.4], 150 mM NaCl, 0.5% Triton X-100) containing 1 protease inhibitor and 1 mM PMSF. The
indicated portion of cell lysates was incubated with protein G magnetic beads prebound with rat anti-HA
or mouse anti-FLAG antibody at 4°C for 1 h with rotation. After washing with IP-lysis buffer was
performed, proteins bound to the beads were solubilized in SDS loading buffer by boiling for 5 min and
were examined by Western blot (WB) analysis using the indicated antibody. The image is representative
of results from two independent experiments with similar outcomes.
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average of 293 cysts, whereas, as expected, no detectable cysts were found in the
brains of Lewis rats. F344 rats infected with Δgra35, Δgra42, or Δgra43 parasites
contained reduced cyst numbers (73 cysts, 55 cysts, and 0 cysts on average per brain
of rats infected with Δgra35, Δgra42, and Δgra43 parasites, respectively) (Fig. 9A). This
suggests that GRA35, GRA42, and GRA43 determine in vivo fitness independently of
their role in inflammasome activation. This was expected for GRA42 and GRA43, as
Δgra42 and Δgra43 parasites have a defect in correct trafficking of GRAs to the PVM and
because some PVM GRAs, such as GRA17, determine parasite fitness (31). The absence
of parasites in the brain of Δgra43 parasite-infected F344 rats was confirmed by
diagnostic PCR based on the Toxoplasma B1 gene (Fig. 9B), which represents a
repetitive sequence in its genome (33). Reduced cyst numbers in F344 rats could have
been due to a defect of Δgra35, Δgra42, or Δgra43 parasites in cyst formation. However,
Δgra35, Δgra42, and Δgra43 parasites formed normal in vitro cysts under alkaline stress
induction conditions (Fig. S7C), suggesting that these GRAs play no role in cyst
formation. Lewis rats infected with Δgra35, Δgra42, or Δgra43 parasites did not contain
any brain cysts. Because GRA35, GRA42, and GRA43 determine in vivo fitness indepen-
dently of their role in inflammasome activation, as shown by their defect in forming
cysts in F344 rats, we cannot make conclusions on the contribution of NLRP1 inflam-
masome activation to Lewis rat sterile immunity to Toxoplasma.
Although the Δgra35, Δgra42, or Δgra43 parasites seemed to be generally much less
virulent than WT parasites in F344 rats, we hypothesized that their initial replication in
macrophages in Lewis rats might still allow them to reach higher parasite numbers and
FIG 9 Parasites lacking GRA35, GRA42, and GRA43 do not establish a chronic infection in Lewis rats. (A) The
number of brain cysts from each rat was determined by FITC-DBA staining at 60 days postinfection. Each plot
represents the number of brain cysts of an individual rat (n  3; *, P 0.05 [one-way ANOVA with Kruskal-Wallis
test]). (B) The presence of Toxoplasma genomic DNA in the brain of infected rats was detected by diagnostic PCR
targeting the multicopy B1 gene. As an internal control, rat actin was used to check the quality of isolated DNA.
The image is representative of results from two independent experiments. (C) The rat serum was obtained at
60 days postinfection. The anti-Toxoplasma IgG titers were quantified by ELISA. Titers were defined as the dilutions
which gave an OD405 reading at least 2-fold higher than the mean background in uninfected rat serum. Results are
presented as mean values  SD obtained from individual infected rats (n  3).
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dissemination levels than WT parasites. Previously, it was determined that higher
parasite burdens in Lewis rats lead to higher anti-Toxoplasma antibody titers (2). We
therefore compared the anti-Toxoplasma IgG titers in the sera obtained from all rats at
2 months postinfection (Fig. 9C). Lewis rats infected with ME49-RFP parasites had lower
anti-Toxoplasma IgG titers (1/3,200 to 1/6,400) than F344 rats (titers  1/25,600). Lewis
rats infected with Δgra35, Δgra42, or Δgra43 parasites had increased anti-Toxoplasma
IgG titers (1/6,400 to 1/12,800, 1/6,400 to 1/25,600, or 1/12,800 to 1/25,600, respec-
tively), whereas the titers were slightly decreased in F344 rats infected with Δgra42 or
Δgra43 parasites (Fig. 9C). The increased titers of Lewis rats infected with Δgra35,
Δgra42, or Δgra43, compared to WT parasite-infected rats, might indicate that Δgra35,
Δgra42, or Δgra43 parasites bypassed the NLRP1 inflammasome barrier in macro-
phages, allowing them to replicate and disseminate. We were unable to observe
detectable IL-1 levels in the serum of parasite-infected Lewis rats and F344 rats
regardless of parasite strain (data not shown). Taking the data together, even though
deletion of GRA35, GRA42, and GRA43 abrogates Lewis rat macrophage pyroptosis,
thereby allowing Δgra35, Δgra42, and Δgra43 parasites to replicate inside Lewis rat
macrophages in vitro, Toxoplasma parasites deficient in these genes still failed to
develop cysts in the brain of Lewis rats. The most likely explanation is that these GRAs
are also required for in vivo fitness independently of their role in Lewis rat inflam-
masome activation.
DISCUSSION
We and others previously showed that Toxoplasma infection activates the NLRP1
inflammasome in Lewis rat macrophages, resulting in pyroptosis, secretion of mature
IL-1, and inhibition of parasite replication (4–6). This study showed that GRA35,
GRA42, and GRA43 are parasite PV-localized proteins that mediate Lewis rat macro-
phage pyroptosis and secretion of mature IL-1. The fact that Δasp5 parasites, but not
Δmyr1 parasites, no longer induced pyroptosis suggests that this cell death is mediated
by PVM-localized GRAs. Several GRAs secreted onto the PVM have been identified as
parasite effectors involved in host-parasite interactions, including modulation of host
signaling pathways, evasion of host immune responses, and nutrition acquisition (23).
GRA6 locates at the PVM, where it selectively activates the host transcription factor
nuclear factor of activated T cells 4 (NFAT4) via interaction with host calcium modu-
lating ligand (CAMLG) (34). GRA7 is a transmembrane protein that spans the PV and
extends into the host cytosol, where it interacts with ROP complexes (35). GRA7 also
binds directly to oligomers of the immunity-related GTPase Irga6, eventually leading to
disassembly (35). GRA15 from type II Toxoplasma, another PVM-associated GRA, is
involved in host NF-B activation, which promotes the production of proinflammatory
cytokines (36). Two additional dense granule proteins, GRA17 and GRA23, which are
also located at the PV membrane, are responsible for small-molecule transport between
the host cytosol and the vacuole lumen (31).
Although our results indicate that Toxoplasma GRAs localized to the PVM induced
Lewis rat macrophage pyroptosis, the mechanism of inflammasome activation is still
unclear. Cleavage of the NLRP1 N terminus is required for the activation of the
inflammasome by anthrax LT (15). A recent study demonstrated that proteolysis can act
as a common activator of diverse NLRP1 variants from mice and humans (37). The
mechanism that emerges is that the N-terminal part, upon autocleavage of NLRP1 at
the FIIND domain, inhibits the active C-terminal part of NLRP1, which contains the
CARD domain. Therefore, degradation of this N-terminal part is needed for inflam-
masome activation (38, 39). GRA35, GRA42, and GRA43 have orthologues in Hammon-
dia, Neospora, and Besnoitia. Neospora caninum is able to induce pyroptosis in Lewis rat
macrophages (Fig. S8), suggesting that the mechanism of inflammasome activation is
conserved in cyst-forming coccidia. GRA42 and GRA43 are mainly localized inside the
PV, suggesting that they are the upstream mediators of inflammasome activation. As
our results show that deletion of GRA42 or GRA43 affects the correct localization of
other PVM GRAs, it is likely that GRA42 and GRA43 function as protein chaperones that
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help GRAs localize to the PVM, where GRA35 or another, unknown GRA then activates
the NLRP1 inflammasome either directly or indirectly. The mutations of GRA35 in
mutant 3 and mutant 4 are in the transmembrane domain, which results in GRA35
lacking its entire C terminus containing two coiled-coil domains. Coiled-coil domains
function in many biological processes, including protein-DNA binding and protein-
protein interaction (40). However, no direct interaction between Lewis rat NLRP1 and
Toxoplasma GRA35 was found in cotransfected HEK293T cells. This suggests that GRA35
might also function as part of the GRA42/GRA43 complex upstream of the protein
involved in NLRP1 inflammasome activation. Previously, we reported that parasite
infection of murine macrophage cell lines or human fibroblasts stably expressing Lewis
rat NLRP1 does not trigger cell death (5). This suggests that murine macrophages and
human fibroblasts lack a factor needed for activation of the Lewis rat NLRP1 inflam-
masome by Toxoplasma. One hypothesis is that GRA35 or another, unknown PVM-
localized GRA interacts with a rat-specific factor that subsequently mediates the
activation of the NLRP1 inflammasome. This pattern has been demonstrated for GRA6,
whose C terminus interacts with host cytosolic protein CAMLG, leading to NFAT4
activation (34). It is also possible that a Toxoplasma protein interacts with or modifies
a Lewis rat-specific protein which is sensed by NLRP1, similarly to NLRC4 recognition of
a NAIP5/NAIP6/flagellin complex (41, 42), or possibly inhibits the negatively regulation
of NLRP1 by this rat factor. A further complication is that some inflammasomes do not
directly interact with a pathogen-associated molecular pattern (PAMP) but rather sense
changes to the cellular milieu induced by infection. For example, NLRP3 senses diverse
cellular signals, such as K efflux, Ca2 signaling, reactive oxygen species (ROS),
mitochondrial dysfunction, and lysosomal rupture, which are the triggers for NLRP3
inflammasome activation (43). It is therefore possible that NLRP1 does not directly
interact with a Toxoplasma effector but rather detects changes in the cell induced by
Toxoplasma infection. For instance, cytosolic ATP depletion is sensed by NLRP1b,
leading to inflammasome activation (44, 45). Another hypothesis is that GRA35 may
also function as part of a putative GRA42/GRA43 complex that affects the PVM platform
that supports or modifies other parasite effectors that somehow activate the NLRP1
inflammasome. This model has been described for the ROP5/ROP18/ROP17/GRA7
complex, which locates at the PVM and prevents PVM rupture by preventing the
accumulation of immunity-related GTPases (IRGs) (35, 46).
Although ASP5 influences GRA35 localization, there is no TEXEL motif present in
GRA35 or in GRA42 and GRA43, suggesting that these three proteins are not direct
substrates of ASP5. It is likely that another protein with a TEXEL motif mediates GRA35
localization to the PVM or functions as a regulator of GRA42 and GRA43 function.
Identification of this protein could help us gain a better understanding of the mech-
anism of NLRP1 inflammasome activation.
Because GRA42 and GRA43 are important for correct localization of other GRAs at
the PVM (Fig. 7B and C), some of which determine parasite fitness (31), it was expected
that parasites lacking GRA42 or GRA43 would be less virulent in vivo. This was what we
observed, as they had a defect in tissue cyst formation in susceptible F344 rats.
However, this also made it difficult to establish the role of GRA42/GRA43-induced
macrophage pyroptosis in Lewis rat sterile immunity. Unexpectedly, parasites
lacking GRA35 were also unable to establish a chronic infection in Lewis rats.
Because parasites lacking GRA35 also had a defect in tissue cyst formation in
susceptible F344 rats, which possess a Toxoplasma-resistant variant of Nlrp1, and
because F344 rat macrophages do not undergo pyroptosis in vitro, GRA35, like
GRA42 and GRA43, must have an inflammasome-independent role in the patho-
genesis of the parasite in vivo.
Despite the failure in tissue cyst formation, the higher anti-Toxoplasma IgG titers in
the serum of Lewis rats infected with Δgra35, Δgra42, or Δgra43 parasites possibly
indicate that pyroptosis was not induced during acute infection, allowing limited
proliferation of tachyzoites, but that these parasites were eventually eliminated by
other mechanisms. However, no parasites were detected in the peritoneal organs
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(spleen and liver) or the peritoneal cavity of Lewis rats and Toxoplasma-susceptible
F344 rats by B1 sequence PCR and in vivo imaging at 2 days postinfection (data not
shown), suggesting that, in general, the rat is resistant to the initial stage of infection.
It remains unclear what mechanisms mediate parasite resistance in rats in which
Toxoplasma does not activate the NLRP1 inflammasome (e.g., F344 rats).
Overall, the results presented here show that three dense granule proteins of
Toxoplasma gondii are necessary for Lewis rat macrophage pyroptosis, which we have
previously shown is induced by NLRP1 inflammasome activation (5). How these pro-
teins function to activate the NLRP1 inflammasome is not yet known, but the data
suggest a model where GRA42 and GRA43 mediate localization of GRA35 or of another,
unknown GRA to the PVM, where it indirectly or directly mediates the activation of the
NLRP1 inflammasome. Future experiments will be needed to determine the precise
mechanism by which PVM-localized GRAs mediate the activation of the NLRP1 inflam-
masome and by which GRA42 and GRA43 influence the localization of GRAs to the PVM.
MATERIALS AND METHODS
Ethics statement. All animal experiments were performed in strict accordance with the recommen-
dations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and
the Animal Welfare Act, approved by the Institutional Animal Care and Use Committee at the University
of California, Davis (UC Davis) (assurance number A-3433-01).
Reagents and antibodies. ENU and EMS were purchased from Sigma-Aldrich. CellTiter 96 AQueous
One Solution cell proliferation assay was obtained from Promega. Dextran sulfate sodium salt was
obtained from Santa Cruz Biotechnology. LPS Escherichia coli O55:B5 (catalog no. 437625) was purchased
from Calbiochem/EMD Biosciences. Caspase-1 inhibitor VX765 was purchased from Selleck Chemicals.
NLRP3 inflammasome inhibitor MCC950 was purchased from AdipoGen Life Sciences, Inc. Nigericin
(sodium salt) was purchased from MilliporeSigma. Rabbit anti-IL-1 (Ab9787) was purchased from
Abcam. Rat anti-HA (3F10) antibody was obtained from Roche. Mouse anti-FLAG M2 antibody (F1804)
was purchased from Sigma-Aldrich. Secondary horseradish peroxidase (HRP)-conjugated antibodies were
purchased from Jackson ImmunoResearch. Alexa Fluor 448 and 594 secondary antibodies were obtained
from Invitrogen.
Rats and parasites. Lewis (LEW/Crl; LEW) rats and F344 (F344/DuCrl; CDF) rats (6 to 8 weeks of age)
were purchased from Charles River Laboratories (Wilmington, MA). Lewis rat bone marrow-derived
macrophages (BMDMs) were prepared as previously described (5). Type I (RH) Toxoplasma gondii
tachyzoites expressing luciferase and green fluorescent protein (GFP) were used for mutagenesis. RH
parasites without luciferase and lacking the HXGPRT gene (RH Δhxgprt parasites) were used for gener-
ating knockouts. RH parasites without luciferase and lacking the HXGPRT gene and the Ku80 gene (RH
Δhxgprt Δku80 parasites) were used as WT controls for Δasp5 parasites. Type II (ME49) parasites
engineered to express RFP were a gift from Michael Grigg. RH Δsub1 parasites were a kind gift from Vern
Carruthers and were generated as previously described (47). RH Δasp5 and RH-ASP5-Ty parasites were
kind gifts from Mohamed-Ali Hakimi and were generated as previously described (26). All parasite strains
were routinely passaged in vitro in monolayers of HFFs. PCR was used to confirm that all strains and cells
were Mycoplasma negative.
Mutagenesis screen. Intracellular RH parasites expressing GFP and luciferase were treated with ENU
(40 M), EMS (100 M), or DMSO for 4 h. Parasites were washed three times with phosphate-buffered
saline (PBS), lysed by the use of a syringe, and allowed to infect fresh HFFs. For selection, Lewis BMDMs
were infected with parasite populations (MOI  0.2 to 0.3) for 2 h. Noninvading parasites were removed
by washing cells with PBS three times. The medium was replaced with medium containing 30 mg/ml
dextran sulfate. At 24 h postinfection, extracellular parasites were removed by washing cells with PBS
three times. Cells were scraped into fresh media and overlaid onto fresh HFFs. After nine rounds of
selection, parasites were cloned via serial dilution. Parasite DNA was isolated using a Qiagen DNeasy
blood & tissue kit according to the manufacturer’s protocol. Illumina sequencing was performed on an
Illumina HiSeq 2000 or MiSeq system. Reads were aligned using type I GT1 (v9.0) as the reference
genome.
Plasmid construction for ectopic expression and generation of complementation strains. The
plasmids were generated by cloning the gene with its putative promoter (2,000 bp upstream of the
start codon) with a C-terminal hemagglutinin (HA) tag sequence into pENTR using TOPO cloning
(Invitrogen) and then into pTKOatt using LR recombination (Invitrogen) (36). The primer sequences are
available in Table S1.
Generation of parasite strains. Individual knockouts of candidate genes were performed using
clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9. Sequences targeting candidate
genes were cloned into the pSS013-Cas9 vector (48). The sequences are available in Table S1. To generate
the MYR1 knockout strain and the knockout strains for the candidate hits from sequenced mutant clones,
plasmids containing single guide RNA (sgRNAs) were cotransfected with XhoI (New England Biolabs)-
linearized pTKOatt, which contains the HXGPRT selection cassette (36), into RH Δhxgprt parasites at a 10:1
ratio (sgRNAs/linearized pTKOatt plasmid). At 24 h posttransfection, populations were selected with
mycophenolic acid (50 g/ml) and xanthine (50 g/ml) and cloned by limiting dilution (Fig. S2A).
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Knockout was assessed by PCR (Fig. S2C). For generating complemented strains, knockout strains
(Δgra35, Δgra42, or Δgra43 parasites) or mutant strains (mutant 1, mutant 2, or mutant 3) were
cotransfected with the linearized complemented plasmid and a plasmid containing the dihydrofolate
reductase (DHFR) resistance cassette at a ratio of 20:1. At 24 h posttransfection, populations were
selected with pyrimethamine (1 M) and cloned by limiting dilution. The presence of the tagged gene
was determined by immunofluorescence assay (IFA) and Western blotting. To generate the double and
triple knockout strains, Δgra35 parasites were cotransfected with separate plasmids containing sgRNAs
against GRA42 or GRA43 together with NotI (New England Biolabs)-linearized pLoxp-DHFR-mCherry (49),
which also contains a pyrimethamine resistance cassette, at a ratio of 5:1 (Fig. S2B). After two rounds of
pyrimethamine selection and limiting dilution cloning, the double and triple knockout parasites were
assessed by PCR and confirmed by sequencing in both loci. The GRA42 and GRA43 double knockout
strain was generated from Δgra42 parasites by using a similar strategy. To generate each T. gondii
GT1_225160 (TGGT1_225160), GRA36, or TGGT1_257970 knockout strain, plasmids containing sgRNAs
were cotransfected with NotI (New England Biolabs)-linearized pLoxp-DHFR-mCherry at a ratio of 5:1
(Fig. S5A). After two rounds of pyrimethamine selection and limiting dilution cloning, the knockout
parasites were assessed by PCR (Fig. S5B) and confirmed by sequencing.
Cell viability analysis, counts of parasites per vacuole, and IL-1 quantitation. Lewis rat BMDMs
were incubated with or without 50 M VX765 or 10 M MCC950 for 2 h followed by parasite infection.
F344 rat BMDMs were infected with parasites for 24 h. Cell viability was measured by 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay as pre-
viously described (5). Counts of parasites per vacuole were performed as previously described (5). In
LPS-primed BMDMs, the culture supernatants were collected for IL-1 quantitation by enzyme-linked
immunosorbent assay (ELISA) as previously described (5). IL-1 in infected cell culture supernatants was
also concentrated using Amicon filters (3-kDa molecular weight cutoff) (Millipore) and detected by
Western blotting.
Coimmunoprecipitation. Plasmids expressing a C-terminal HA-tagged GRA35 without signal pep-
tide (pcDNA3.1-GRA35-HA) and an N-terminal FLAG-tagged Lewis rat variant of NLRP1 (pCMV-FLAG-
NLRP1) were mixed at a 1:1 ratio and transfected into HEK293T cells using X-tremeGENE 9 DNA
transfection reagent (Roche) according to the manufacturer’s instructions. As controls, cells were also
transfected with GRA35-HA plus FLAG empty vector and pcDNA3.1 empty vector plus FLAG-NLRP1 under
the same conditions. After 30 h of transfection, cells were lysed in IP-lysis buffer (50 mM Tris [pH 7.4],
150 mM NaCl, 0.5% Triton X-100) containing 1 protease inhibitor and 1 mM phenylmethylsulfonyl
fluoride (PMSF). The cell lysates were incubated with protein G magnetic beads prebound with rat
anti-HA or mouse anti-FLAG antibody at 4°C for 1 h with rotation. After washing with IP-lysis buffer was
performed, proteins bound to the beads were solubilized in SDS loading buffer by boiling for 5 min and
examined by Western blot analysis. GRA35-HA was detected by rat anti-HA antibody, and FLAG-NLRP1
was detected by mouse anti-FLAG antibody.
Western blotting. To detect activated IL-1, concentrated culture supernatants were separated on
12% SDS-PAGE gels and transferred to a polyvinylidene difluoride (PVDF) membrane (Bio-Rad, USA). To
detect HA-tagged-GRA35, GRA42, or GRA43 expression, cell lysates made from intracellular parasites and
extracellular parasites were separated onto 12% SDS-PAGE gels and transferred to a PVDF membrane. To
detect interactions between GRA35-HA and FLAG-NLRP1, the coimmunoprecipitated samples were
separated onto 12% SDS-PAGE gels and transferred to a PVDF membrane. Western blot analysis was
performed as previously described (36).
Invasion assay. Lewis rat BMDMs were incubated with or without 50 M VX765 or 10 M MCC950
for 2 h followed by parasite infection. After 30 min of infection, a red/green invasion assay was performed
as previously described (50) for indirect analysis of immunofluorescence.
Immunofluorescent assay. Extracellular parasites released from syringe-lysed HFFs were loaded
onto coverslips and fixed with 100% ice-cold methanol for 5 min. Colocalization studies were performed
with anti-GRA7 or anti-ROP1 and anti-HA antibodies. Alexa Fluor 488 and 594 secondary antibodies were
used as previously described (36). To determine the localization of GRAs inside host cells, HFFs were
infected with the different parasite strains for 24 to 30 h, fixed with 3% formaldehyde for 20 min, and
permeabilized with 0.2% Triton X-100, followed by staining with rat anti-HA antibodies (1/500 dilution)
or mouse monoclonal antibodies against Toxoplasma surface antigen (SAG1). Alexa Fluor 488 and 594
secondary antibodies were used as previously described (36).
In vitro cyst induction. Parasites were propagated in HFFs on coverslips under bradyzoite-inducing
conditions (RPMI 1640 medium supplemented with 50 mM HEPES and 1% fetal bovine serum [pH 8.2],
ambient CO2) for 3 days. Cells were then fixed with 100% ice-cold methanol and permeabilized with 0.2%
Triton X-100, and the cysts were stained by the use of fluorescein isothiocyanate-Dolichos biflorus
agglutinin (FITC-DBA) (Vector Laboratories).
In vivo infection, cyst counting, diagnostic PCR, and serological detection. Toxoplasma
tachyzoites were harvested from cell culture and released by passage through a 27-gauge needle,
followed by a 30-gauge needle. Three Lewis rats and three F344 rats (8 weeks of age) were infected
intraperitoneally (i.p.) with 2 106 parasites of each strain, and the parasite viability of the inoculums was
determined in a plaque assay after infection. At 60 days postinfection, the rats were sacrificed and the
brains were harvested. Following homogenization of brains by passage though a 21-gauge needle, cysts
were stained by the use of FITC-DBA. To detect the presence of parasite in the brains of infected rats,
genomic DNA of homogenized brains was isolated using Qiagen DNeasy blood & tissue kits (Qiagen).
Diagnostic PCR targeting the B1 gene was performed using the primer sets listed in Table S1. To
determine the anti-Toxoplasma IgG response of infected rats, serum was separated from blood obtained
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at 60 days postinfection and the anti-Toxoplasma IgG titer was determined using an enzyme-linked
immunosorbent assay (ELISA). The plates were coated with 0.25 g of whole-parasite lysate produced by
several freeze-thaw cycles. After blocking with 2% bovine serum albumin (BSA)–PBS–0.05% Tween
20 was performed, serial dilutions of serum were added and the reaction mixtures were incubated
at room temperature for at least 2 h, followed by incubation with 1/2,000-diluted HRP-conjugated
goat anti-rat IgG at room temperature for 2 h. Finally, after washing with PBS–0.05% Tween 20 was
performed, 100 l of substrate solution {ABTS [2,2=-azinobis(3-ethylbenzthiazolinesulfonic acid)]
solution; Sigma} was added to the wells, and after 30 min, the reaction was stopped by the addition
of 50 l of 0.3 M oxalic acid and the optical density at 405 nm (OD405) was measured. The titer
corresponds to the dilution which gave an OD405 reading that was 2-fold higher than the average
seen with uninfected rat serum.
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